You're going to hear a lot more about "ASA resistance"
May 2003
You're going to hear a lot more about "ASA resistance." Now that millions of people take low-dose ASA to prevent cardiovascular disease, we're seeing that it doesn't always work.
About 10% of the population might be resistant to ASA's antiplatelet effects. These patients might be up to 3 times more likely to die of cardiovascular disease.
Two tests for ASA resistance are already on the market... AspirinCheck and AspirinWorks.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote